A common drug used to treat type 2 diabetes may prevent natural and man-made chemicals from stimulating the growth of cancer cells, suggests a new study from Michigan State University (MSU) and South Korea’s Seoul National University. The study looked at long-term use of the drug metformin and its ability to reduce the risk of diabetes-associated cancers such as cancers of the breast, liver and pancreas. Researchers say they found metformin reduced the risk for these cancers but there was no evidence of how it worked. Metformin is an oral medication used to treat diabetes and is often the first ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.